logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10786555 B1

PDFFull Text
Date of Patent:
Sep. 29, 2020

Filed:

Dec. 03, 2018

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

Applicant:

Applied Molecular Transport Inc., South San Francisco, CA (US);

Inventors:

Randall J. Mrsny, Los Altos Hills, CA (US);

Tahir Mahmood, Burlingame, CA (US);

Assignee:

Applied Molecular Transport Inc., South San Francisco, CA (US);

Attorney:

Wilson Sonsini Goodrich & Rosati

Primary Examiner:

Robert A Zeman

Int. Cl.
CPC ...
A61K 38/45 (2006.01); C07K 14/54 (2006.01); A61K 38/16 (2006.01); A61K 38/20 (2006.01); A61K 38/26 (2006.01); A61K 38/48 (2006.01); A61K 38/49 (2006.01); A61K 38/50 (2006.01); A61K 38/51 (2006.01); A61K 38/27 (2006.01); A61K 38/17 (2006.01); C07K 16/24 (2006.01);
U.S. Cl.
CPC ...
A61K 38/45 (2013.01); A61K 38/164 (2013.01); A61K 38/166 (2013.01); A61K 38/1793 (2013.01); A61K 38/20 (2013.01); A61K 38/2066 (2013.01); A61K 38/26 (2013.01); A61K 38/27 (2013.01); A61K 38/482 (2013.01); A61K 38/49 (2013.01); A61K 38/50 (2013.01); A61K 38/51 (2013.01); C07K 14/5428 (2013.01); C07K 16/241 (2013.01); C12Y 204/02036 (2013.01); C12Y 304/21068 (2013.01); C12Y 304/21073 (2013.01); C12Y 305/04004 (2013.01); C12Y 402/02001 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01); C07K 2319/21 (2013.01); C07K 2319/30 (2013.01); C07K 2319/32 (2013.01); C07K 2319/50 (2013.01); C07K 2319/55 (2013.01); C07K 2319/60 (2013.01); C07K 2319/90 (2013.01);
Abstract

The present disclosure relates to pharmaceutical compositions comprising a non-naturally occurring fusion molecule and one or more pharmaceutically acceptable carriers, formulated for oral delivery to a subject, and designed to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases, autoimmune diseases, cancer, metabolic disorders, and growth deficiency disorders.

Find Patent Forward Citations

Mrsny, Randall. (2020). Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (U.S. Patent No. 10786555). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10786555

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…